MUC1-EGFR Crosstalk with IL-6 by Activating NF-κB and MAPK Pathways to Regulate the Stemness and Paclitaxel-Resistance of Lung Adenocarcinoma

0
56
The bioinformatics method was used to analyze the mRNA and protein expression characteristics of MUC1 in lung adenocarcinoma (LUAD).
[Annals of Medicine]
Full Article